Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Pain Research (Lausanne, Switzerland)|February 16, 2026
The nonhallucinogenic ketamine metabolite (2R,6R)-hydroxynorketamine is a novel analgesic in animal models of painBruno Carabelli, Caroline A Browne, Irwin Lucki
Journal of Pharmacological Sciences|September 22, 2025
(2R,6R)-hydroxynorketamine reverses mechanical and thermal pain hypersensitivity produced by the chemotherapeutic agent oxaliplatin in ratsMaria Campanile, Kaitlin Castell, Justin O Pampalone, et al.
CNS & Neurological Disorders Drug Targets|April 10, 2012
Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studiesMarcelo M S Lima, Emerson F Martins, Ana Marci Delattre, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2026
Genetic alterations in SUPT6H are associated with neurodevelopmental disordersBruno Carabelli, Hyung-Goo Kim, Bonsu Ku, et al.
Behavioural Brain Research|May 15, 2020
Fish-oil supplementation decreases Indoleamine-2,3-Dioxygenase expression and increases hippocampal serotonin levels in the LPS depression modelBruno Carabelli, Ana Márcia Delattre, Ana Paula Farias Waltrick, et al.
The European Journal of Neuroscience|November 7, 2013
Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomised ratsClaudia Pudell, Bianca A Vicente, Ana M Delattre, et al.
Molecular Neurobiology|August 21, 2014
The Antidepressant-Like Effect of Fish Oil: Possible Role of Ventral Hippocampal 5-HT1A Post-synaptic ReceptorBruno Carabelli, Ana Marcia Delattre, Claudia Pudell, et al.
Pageof 2